Optimized cytotoxicity assay for co-suspended effector and target cells

Journal of Immunological Methods - Tập 497 - Trang 113100 - 2021
Lei Cui1, Feng Yin1, Jingbo Cheng1, Hui Liu1, Meimei Zheng1, Di Liu1, Zeji Wu1, Qiqun Qian1
1Shanghai Cell Therapy Group Co., LTD, Shanghai 201805, China

Tài liệu tham khảo

Bossi, 2013, Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells, Oncoimmunology, 2, 10.4161/onci.26840

Eyquem, 2017, Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection, Nature, 543, 113, 10.1038/nature21405

Jiang, 2007, Induction of cytotoxic T lymphocytes specific to malignant glioma using T2 cells pulsed with HLA-A2-restricted interleukin-13 receptor alpha 2 peptide in vitro, Acta Biochim. Biophys. Sin., 39, 641, 10.1111/j.1745-7270.2007.00331.x

Khalaf, 2019, In vitro generation of cytotoxic T cells with potential for adoptive tumor immunotherapy of multiple myeloma, Front. Immunol., 10, 1792, 10.3389/fimmu.2019.01792

Neri, 2001, Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants, Clin. Diagn. Lab. Immunol., 8, 1131, 10.1128/CDLI.8.6.1131-1135.2001

Nevi, 2017, Cryopreservation protocol for human biliary tree stem/progenitors, hepatic and pancreatic precursors, Sci. Rep., 7, 6080, 10.1038/s41598-017-05858-0

Smith, 2011, A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time, PLoS One, 6, 10.1371/journal.pone.0026908

Wang, 2020, PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma, Immunobiology, 225, 151850, 10.1016/j.imbio.2019.09.009